{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:11:57Z","timestamp":1762459917266,"version":"3.41.2"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Bone marrow stromal cells (BMSCs) has been reported to have beneficial effects in improving behavioral deficits, and rescuing dopaminergic neuron loss in rodent models of Parkinson's disease (PD). However, their pooled effects for dopaminergic neuron have yet to be described.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To review the neuroprotective effect of na\u00efve BMSCs in rodent models of PD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The PubMed, EMBASE, and Web of Science databases were searched up to September 30, 2020. Inclusion criteria according to PICOS criteria were as follows: (1) population: rodents; (2) intervention: unmodified BMSCs; (3) comparison: not specified; (4) primary outcome: tyrosine hydroxylase level in the substantia nigra pars compacta and rotational behavior; secondary outcome: rotarod test, and limb function; (5) study: experimental studies. Multiple prespecified subgroup and meta-regression analysis were conducted. Following quality assessment, random effects models were used for this meta-analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-seven animal studies were included. The median quality score was 4.7 (interquartile range, 2\u20138). Overall standardized mean difference between animals treated with na\u00efve BMSCs and controls was 2.79 (95% confidence interval: 1.70, 3.87; <jats:italic>P<\/jats:italic> &amp;lt; 0.001) for densitometry of tyrosine hydroxylase-positive staining; \u22121.54 (95% confidence interval: \u22122.11, \u22120.98; <jats:italic>P<\/jats:italic> &amp;lt; 0.001) for rotational behavior. Significant heterogeneity among studies was observed.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Results of this meta-analysis suggest that na\u00efve BMSCs therapy increased dopaminergic neurons and ameliorated behavioral deficits in rodent models of PD.<\/jats:p>","DOI":"10.3389\/fnagi.2020.539933","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T10:59:03Z","timestamp":1607684343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Bone Marrow Stromal Cells in Parkinson's Disease Rodent Model: A Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jianyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/sctm.19-0430","article-title":"Mesenchymal stem cells as a multimodal treatment for nervous system diseases","volume":"9","author":"Badyra","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3349\/ymj.2011.52.3.401","article-title":"Neuron-like differentiation of bone marrow-derived mesenchymal stem cells","volume":"52","author":"Bae","year":"2011","journal-title":"Yonsei Med. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/scd.2007.0172","article-title":"Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols","volume":"17","author":"Barzilay","year":"2008","journal-title":"Stem Cells Dev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12015-014-9551-y","article-title":"Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids","volume":"11","author":"Berg","year":"2015","journal-title":"Stem Cell Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/bmj.311.7013.1145","article-title":"Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons","volume":"311","author":"Campbell","year":"1995","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/jnr.24442","article-title":"Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease","volume":"97","author":"Cucarian","year":"2019","journal-title":"J. Neurosci. Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3109\/14653249.2011.579957","article-title":"Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells","volume":"13","author":"Datta","year":"2011","journal-title":"Cytotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1007\/s00018-006-6191-7","article-title":"Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells","volume":"63","author":"Dezawa","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1172\/JCI200420935","article-title":"Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation","volume":"113","author":"Dezawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","article-title":"Current pharmaceutical treatments and alternative therapies of Parkinson's disease","volume":"14","author":"Dong","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jpepsy\/jsp004","article-title":"How to select, calculate, and interpret effect sizes","volume":"34","author":"Durlak","year":"2009","journal-title":"J. Pediatr. Psychol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","article-title":"Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy","volume":"77","author":"Fan","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.expneurol.2013.03.016","article-title":"Mesenchymal stem cells and neuroregeneration in Parkinson's disease","volume":"247","author":"Glavaski-Joksimovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9140541","DOI":"10.1155\/2016\/9140541","article-title":"Therapeutic effects of CUR-activated human umbilical cord mesenchymal stem cells on 1-Methyl-4-phenylpyridine-induced Parkinson's disease cell model","volume":"2016","author":"Jinfeng","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/0963689718766324","article-title":"Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a rodent model of Parkinson's disease","volume":"27","author":"Kim","year":"2018","journal-title":"Cell Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15283\/ijsc18110","article-title":"CRISPR\/Cas9 edited sRAGE-MSCs protect neuronal death in Parkinsons disease model","volume":"12","author":"Lee","year":"2019","journal-title":"Int. J. Stem Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1002\/jcp.26192","article-title":"Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases","volume":"233","author":"Lo Furno","year":"2018","journal-title":"J. Cell. Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"Macleod","year":"2004","journal-title":"Stroke"},{"key":"B29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fbioe.2019.00294","article-title":"Bone marrow mesenchymal stem cells' secretome exerts neuroprotective effects in a Parkinson's disease rat model","volume":"7","author":"Mendes-Pinheiro","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/brain\/awu381","article-title":"Dopaminergic modulation of motor network dynamics in Parkinson's disease","volume":"138","author":"Michely","year":"2015","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease","volume":"107","author":"Park","year":"2008","journal-title":"J. Neurochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00401-016-1605-6","article-title":"Mesenchymal stem cells enhance \u03b1-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder","volume":"132","author":"Park","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4103\/ijmr.IJMR_1842_15","article-title":"Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells","volume":"144","author":"Rengasamy","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1089\/scd.2015.0127","article-title":"A meta-analysis of mesenchymal stem cells in animal models of Parkinson's disease","volume":"24","author":"Riecke","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B38","first-page":"167","article-title":"What is your research question? An introduction to the PICOT format for clinicians","volume":"56","author":"Riva","year":"2012","journal-title":"J. Can Chiropr. Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(05)61034-3","article-title":"Sample size calculations in randomised trials: mandatory and mystical","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"23763","DOI":"10.1002\/jcp.28944","article-title":"Olfactory mucosa stem cells: an available candidate for the treatment of the Parkinson's disease","volume":"234","author":"Simorgh","year":"2019","journal-title":"J. Cell Physiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","article-title":"Mesenchymal stromal cell therapies for neurodegenerative diseases","volume":"94","author":"Staff","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"B44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"B46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neulet.2014.10.039","article-title":"Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats","volume":"584","author":"Suzuki","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"931902","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1574888X12666161114122059","article-title":"Mesenchymal stem cells as a source of dopaminergic neurons: a potential cell based therapy for Parkinson's","volume":"12","author":"Venkatesh","year":"2017","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2011.10.038","article-title":"Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor","volume":"1431","author":"Whone","year":"2012","journal-title":"Brain Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2006.07.013","article-title":"Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease","volume":"13","author":"Ye","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jcyt.2018.02.371","article-title":"Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/br.2018.1049","article-title":"Induced pluripotent stem cells in rat models of Parkinson's disease: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2018","journal-title":"Biomed. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s11064-015-1816-6","article-title":"Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons","volume":"41","author":"Zhao","year":"2016","journal-title":"Neurochem. Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2020.539933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T10:59:06Z","timestamp":1607684346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2020.539933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":55,"alternative-id":["10.3389\/fnagi.2020.539933"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.539933","relation":{},"ISSN":["1663-4365"],"issn-type":[{"type":"electronic","value":"1663-4365"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"article-number":"539933"}}